Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement.

Citrome L, Volavka J.

Diabetes Care. 2004 Aug;27(8):2087-8; author reply 2089-90. No abstract available.

PMID:
15277450
2.

Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement.

Citrome L, Volavka J.

J Clin Psychiatry. 2005 Aug;66(8):1073-4. No abstract available.

PMID:
16086627
3.

Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement.

Holt RI.

Diabetes Care. 2004 Aug;27(8):2086-7; author reply 2089-90. No abstract available.

PMID:
15277449
4.

Consensus development conference on antipsychotic drugs and obesity and diabetes.

American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity.

Obes Res. 2004 Feb;12(2):362-8. Review. No abstract available.

5.

Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement.

Boehm G, Racoosin JA, Laughren TP, Katz R.

Diabetes Care. 2004 Aug;27(8):2088-9; author reply 2089-90. No abstract available.

PMID:
15277452
6.

Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement.

Isaac MT, Isaac MB.

Diabetes Care. 2004 Aug;27(8):2088; author reply 2089-90. No abstract available.

PMID:
15277451
7.

Consensus development conference on antipsychotic drugs and obesity and diabetes.

American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity.

J Clin Psychiatry. 2004 Feb;65(2):267-72. Review. No abstract available.

PMID:
15003083
8.

Metabolic effects of treatment with atypical antipsychotics.

Kane JM, Barrett EJ, Casey DE, Correll CU, Gelenberg AJ, Klein S, Newcomer JW.

J Clin Psychiatry. 2004 Nov;65(11):1447-55. No abstract available.

9.

Consensus development conference on antipsychotic drugs and obesity and diabetes.

American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity.

Diabetes Care. 2004 Feb;27(2):596-601. Review. No abstract available.

PMID:
14747245
10.

Development of guidelines for preventing and managing obesity and diabetes in mentally ill patients.

Gupta S, Frank BL.

J Clin Psychiatry. 2004 Aug;65(8):1149. No abstract available.

PMID:
15323609
11.

Weight gain and diabetes with "second-generation" antipsychotic drugs.

Firestone A.

Med J Aust. 2005 Jun 20;182(12):652-3. No abstract available.

PMID:
15963026
13.

Scientific standards: critical comments on the pharmacoepidemiological study of second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia.

Cohen D.

J Clin Psychopharmacol. 2008 Aug;28(4):461-2; author reply 462-4. doi: 10.1097/JCP.0b013e318172c7e0. No abstract available.

PMID:
18626279
14.

Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.

Cohen D, Dekker JJ, Peen J, Gispen-de Wied CC.

Eur Neuropsychopharmacol. 2006 Apr;16(3):187-94. Epub 2005 Nov 2.

PMID:
16263247
15.

Prevention of obesity and diabetes.

Bloomgarden ZT.

Diabetes Care. 2003 Nov;26(11):3172-8. Review. No abstract available.

PMID:
14578257
16.
17.

Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes: response to Lean and Pajonk.

Hardy T, Breier A.

Diabetes Care. 2003 Nov;26(11):3200-1. No abstract available.

PMID:
14578278
18.

GlaxoSmithKline responds to the consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Ambery P, Cobitz AR.

Diabetologia. 2009 May;52(5):986-7. doi: 10.1007/s00125-009-1301-3. Epub 2009 Mar 4. No abstract available.

PMID:
19259643
19.

Lipid management in patients with diabetes mellitus.

Brown AS.

Am J Cardiol. 2005 Aug 22;96(4A):26E-32E. Review.

PMID:
16098840
20.

Type 2 diabetes mellitus in the pediatric population.

Gaylor AS, Condren ME.

Pharmacotherapy. 2004 Jul;24(7):871-8. Review.

PMID:
15303451

Supplemental Content

Support Center